DCT and melanoma: To test our hypothesis that the development of melanoma was driven by the ectopic expression of Grm1 in mouse melanocytes, a second transgenic line was created, Tg(Grm1)EPv, wherein the expression of Grm1 cDNA was regulated by a melanocyte specific promoter, dopachrome tautomerase (Dct) [38].